Barely Significant
← all excerpts

<i>GSTM5</i> as a Potential Biomarker for Treatment Resistance in Prostate Cancer.

Biomedicines · 2025 · PMC12383628 · PMID 40868127

Europe PMCDOI
3
hedged sentences
0.0636
closest p · 1.3× alpha
0.0636
boldest claim

The sentences

a trend toward significancep = 0.0636so close (0.05 < p ≤ 0.1)
GG + GT) also showed a trend toward significance ( p = 0.0636 in Fisher’s test), with a reduced risk of early progression in T/T genotype carriers ( p = 0.0572 in simple logistic regression; OR = 0.22, 95% CI: 0.03–0.88) compared to those with GG + GT genotypes.

also in 2,500 other papers

showed a trendp = 0.0636so close (0.05 < p ≤ 0.1)
GG + GT) also showed a trend toward significance ( p = 0.0636 in Fisher’s test), with a reduced risk of early progression in T/T genotype carriers ( p = 0.0572 in simple logistic regression; OR = 0.22, 95% CI: 0.03–0.88) compared to those with GG + GT genotypes.

also in 33,237 other papers

did not reach statistical significanceno p-value reported
However, this difference did not reach statistical significance, possibly due to the low frequency of the T/T genotype.

also in 75,281 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.